AR019492A1 - PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION - Google Patents

PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION

Info

Publication number
AR019492A1
AR019492A1 ARP990105328A AR019492A1 AR 019492 A1 AR019492 A1 AR 019492A1 AR P990105328 A ARP990105328 A AR P990105328A AR 019492 A1 AR019492 A1 AR 019492A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
controlled liberation
liberation
controlled
formulations
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9823132.7A external-priority patent/GB9823132D0/en
Priority claimed from GBGB9823192.1A external-priority patent/GB9823192D0/en
Priority claimed from GBGB9825117.6A external-priority patent/GB9825117D0/en
Priority claimed from GBGB9826392.4A external-priority patent/GB9826392D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of AR019492A1 publication Critical patent/AR019492A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion proporciona formulaciones farmacéuticas de liberacion controlada para administracion oral que contienen un inhibidor GMPc PDE-5. Lasformulaciones son utiles, entre otros, en el tratamiento o prevencion de la disfuncion sexual.The invention provides controlled release pharmaceutical formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, among others, in the treatment or prevention of sexual dysfunction.

ARP990105328 1998-10-23 1999-10-21 PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION AR019492A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9823132.7A GB9823132D0 (en) 1998-10-23 1998-10-23 Demountable head means
GBGB9823192.1A GB9823192D0 (en) 1998-10-23 1998-10-23 Pharmaceutical formulations
GBGB9825117.6A GB9825117D0 (en) 1998-11-16 1998-11-16 Pharmaceutical formulations
GBGB9826392.4A GB9826392D0 (en) 1998-11-27 1998-11-27 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
AR019492A1 true AR019492A1 (en) 2002-02-20

Family

ID=45569849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105328 AR019492A1 (en) 1998-10-23 1999-10-21 PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION

Country Status (1)

Country Link
AR (1) AR019492A1 (en)

Similar Documents

Publication Publication Date Title
CO5160262A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
GT200100152A (en) NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OBESITY.
AR012671A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PROPHYLAXIS OF THE CONSTIPATION, THE USES OF SUCH COMPOSITIONS AND THE PROCESSES TO PREPARE THEM
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
ES2183937T3 (en) INHIBITORS OF THE CELL ADHESION.
ES2193337T3 (en) USE OF STRONTIUM SALTS FOR THE TREATMENT OF ARTROSIS.
ECSP045004A (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES
ES2191152T3 (en) COMBINED THERAPY FOR THE TREATMENT OF PSYCHOSIS.
GT199700141A (en) PREVENTION OF LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS.
HN2001000266A (en) SELECTIVE AGONISTS OF THE EP4 RECEPTOR IN THE TREATMENT OF OSTEOPOROSIS.
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
SV1998000029A (en) PIRAZINE COMPOUNDS REF. PG3186
AR023423A1 (en) ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES
PA8452701A1 (en) PROSTAGLANDIN AGONISTS
PA8462401A1 (en) DERIVATIVES OF THENOPyrimidine AND THENOPyridine USEFUL AS ANTI-CANCER AGENTS
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
AR015946A1 (en) PHARMACEUTICAL FORMULATION THAT INCLUDES BIFOSPHONATES, PROCESS FOR PREPARATION, USE OF THE FORMULATION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PARALA METHOD INHIBITION OF OSEA REABSORTION, AND METHOD FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS
GT199700009AA (en) COMBINED THERAPY FOR OSTEOPOROSIS
GT200100132A (en) PIRAZOL DERIVATIVES
GT199800177A (en) EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE.
HN2000000166A (en) COMPOSITION OF CLINDAMYCIN INTRAVAGINAL OVULES
PA8543201A1 (en) DERIVATIVES OF DIHIDRO-BENZO [B] [1,4] -DIAZEPIN-2-ONA AS ANTAGONISTS I OF mGluR2
HN2000000268A (en) COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS
GT199900183A (en) GMP DE5 INHIBITING PIRAZOLOPIRIMIDONAS FOR THE TREATMENT OF SEXUAL DYSFUNCTION.
AR046402A1 (en) COMBINATION OF ACTIVE PRINCIPLE THAT INCLUDES A 2,5-DIHYDROBENCENOSULPHONIC COMPOUND AND A POTASSIUM CHANNEL MODULATOR

Legal Events

Date Code Title Description
FC Refusal